Código QR (código de barras bidimensional)

Evidence that Replication of the Antitumor Adenovirus ONYX-015 Is Not Controlled by the p53 and p14(ARF) Tumor Suppressor Genes

The adenovirus mutant ONYX-015 is in phase III clinical trials as a novel antitumor therapy. Its apparent efficacy is thought to be due to its ability to replicate selectively in tumor cells defective in the signaling pathway for p53. Recent data have shown that p14(ARF), a positive regulator of p53...

Fuld beskrivelse

Na minha lista:
Udgivet i:J Virol
Principais autores: Edwards, Sara J., Dix, Brett R., Myers, Colleen J., Dobson-Le, Deirdre, Huschtscha, Lily, Hibma, Merilyn, Royds, Janice, Braithwaite, Antony W.
Format: Artigo
Sprog:Inglês
Udgivet: American Society for Microbiology (ASM) 2002
Fag:
Replication
Online adgang:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC136704/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12438574/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.76.24.12483-12490.2002
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker